Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT

Bone Marrow Transplantation, Published online: 05 August 2023; doi:10.1038/s41409-023-02048-7Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT

Source: Bone Marrow Transplantation - August 5, 2023 Category: Hematology Authors: R émi Tilmont Ibrahim Yakoub-Agha Diderik-Jan Eikema Nienke Zinger Mathias Haenel Nicolaas Schaap Concepcion Herrera Arroyo Christine Schuermans Britta Besemer Monika Engelhardt J ürgen Kuball Mariagrazia Michieli Natalie Schub Keith M. O. Wilson Jean H Source Type: research